Konrad Bleicher, PhDExpert Scientist at F. Hoffmann-La Roche Ltd.
Konrad Bleicher holds a Ph.D. in Organic Chemistry which he received from the Tübingen University in Germany. He started his professional career at Sandoz/Novartis (Switzerland & US) where he gained experience in the area of Combinatorial Chemistry before joining Roche as a scientist in the CNS chemistry department. Since then he has been holding various positions in the Small Molecule Medicinal Chemistry area (Hit ID, Lead ID and Lead Optimization). In 2009 Dr. Bleicher was nominated “Peptide Area Head”, overseeing the peptide chemistry activities in Pharma Research & Early Development. Since 2016 he is responsible for the RNA Therapeutics Chemistry strategy and platform development in Roche Basel. He is the author of over 80 patents and publications and an invited speaker for various international conferences.